平安证券晨会纪要-20250528

Group 1: Pharmaceutical Industry - The 2025 ASCO conference will showcase significant clinical data from domestic innovative drugs, with 71 original research results selected for oral presentations, including 11 major studies [5][6] - Investment opportunities are recommended in companies with global competitiveness in innovative drugs, such as BeiGene, Dongcheng Pharmaceutical, and others [6][7] - The focus is on innovation, overseas expansion, equipment upgrades, and consumer recovery within the pharmaceutical sector [6][7] Group 2: Renewable Energy Industry - The domestic wind power sector is experiencing upward trends, with offshore wind power showing positive export conditions and commercial progress [7][11] - The solar energy sector is facing high inventory levels, with domestic polysilicon inventory at approximately 390,000 tons, leading to reduced production rates [9][11] - Hydrogen energy policies are being implemented in multiple provinces, promoting the economic viability of hydrogen vehicles through highway fee exemptions [10][11] Group 3: Market Performance - The wind power index has decreased by 2.13%, underperforming the CSI 300 index by 1.95 percentage points, with a current PE_TTM valuation of approximately 18.64 times [7] - The solar energy equipment index has also seen a decline of 3.19%, with the solar cell component index down by 1.91% [7] - The energy storage sector is experiencing a decline of 2.06%, with an overall PE ratio of 25.70 times [7]